Compare BRFH & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRFH | QNRX |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9M | 9.2M |
| IPO Year | 2010 | 2023 |
| Metric | BRFH | QNRX |
|---|---|---|
| Price | $0.58 | $4.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $4.00 | ★ $20.38 |
| AVG Volume (30 Days) | ★ 31.1K | 22.7K |
| Earning Date | 11-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.53 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $211,467.00 | N/A |
| Revenue This Year | $60.90 | N/A |
| Revenue Next Year | $27.89 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 92.09 | N/A |
| 52 Week Low | $0.56 | $3.25 |
| 52 Week High | $3.50 | $23.50 |
| Indicator | BRFH | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 29.51 | 43.71 |
| Support Level | $0.56 | $4.03 |
| Resistance Level | $0.74 | $4.50 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 7.35 | 69.57 |
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.